title: Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
abstract: We describe three cases of aorto-ostial lesions with recurrent restenosis after multiple modalities of percutaneous treatment, including sirolimus-eluting stent implantation in all cases and intravascular brachytherapy in one case. In-stent restenosis was successfully managed with polytetrafluoroethylene-covered stents. Six-month angiographic follow-up documented complete patency of the target segment in all patients.
authors.affiliation: Division of Cardiology, Ospedale degli Infermi, Rivoli (TO), Italy. gagnora@libero.it
authors.forename: Andrea
authors.initials: A
authors.lastname: Gagnor
authors.forename: Ferdinando
authors.initials: F
authors.lastname: Varbella
authors.forename: Paolo
authors.initials: P
authors.lastname: Rubartelli
authors.forename: Stefania
authors.initials: S
authors.lastname: Luceri
authors.forename: Maria R
authors.initials: MR
authors.lastname: Conte
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D012008:Recurrence; D019233:Retreatment; D018570:Risk Assessment; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents
chemical_list: D007166:Immunosuppressive Agents; D011138:Polytetrafluoroethylene; D020123:Sirolimus